Search Form
First, enter a politician or zip code
Now, choose a category
 

Amy Klobuchar's Public Statements on Issue: Drugs

Office: U.S. Senate (MN) - Sr, Democratic
Date Title
July 19, 2017 Letter to Richard Baum, Acting Director Office of National Drug Control Policy - Deliver a Strategy to Battle Opioid Addiction
July 11, 2017 Letter to the Hon. Chuck Rosenberg, Acting Administrator of the United States Drug Enforcement Administration - Senators Urge DEA to Lower Opioid Quotas to Combat Prescription Drug Abuse
July 7, 2017 Klobuchar Statement on Reports of Decline in Rate of Opioid Prescribing
July 3, 2017 Klobuchar Presses Three Pharmaceutical Companies for Action on High Insulin Prices; Urges Vigilance Against Anticompetitive Conduct
June 26, 2017 Letter to the Hon. Chuck Rosenberg, Acting Administrator of the United States Drug Enforcement Administration - Senators Call on the DEA to Provide Information to Support First Responders on the Frontlines in the Fight Against Synthetic Opioids
June 26, 2017 Klobuchar, Portman Call on the DEA to Provide Information to Support First Responders on the Frontlines in the Fight Against Synthetic Opioids
June 22, 2017 Klobuchar, Bipartisan Group of Members of Senate Judiciary Committee Urge FDA Commissioner to Address Abuses in the Regulatory Process that Delay Competition and Increase Prescription Drug Costs
May 24, 2017 Letter to the Hon. Donald J. Trump, President - Delay Visit of Filipino Leader, Denounce Human Rights Abuses
May 17, 2017 Pro-Consumer Groups Announce Endorsement of Klobuchar's Legislation to Lower Prescription Drug Prices for Seniors
May 15, 2017 Klobuchar, McCain, Grassley Urge OMB Director Mulvaney to Use Existing Executive Authority to Bring Down Prescription Drug Costs
May 9, 2017 Letter to the Hon. Mick Mulvaney, Director of the Office of Management and Budget - Fully Fund Office of National Drug Control Policy
April 28, 2017 Klobuchar Outlines Minnesota Priorities for Federal Funds to Combat Opioid Crisis Ahead of National Take-Back Day
April 27, 2017 Klobuchar, Leaders of Senate and House Judiciary Committees Introduce Bipartisan Legislation to Counter Rising Prescription Drug Prices
April 20, 2017 Klobuchar Announces $5 Million in Federal Funding to Combat Opioid Addiction in Minnesota
April 11, 2017 Letter to the Hon. Donald Trump, President - Help Fight Opiod Epidemic
April 4, 2017 Rep. Jenkins Introduces Bill to Help Combat Opioid Abuse
March 31, 2017 With New Lethal Strain of Synthetic Heroin From China Causing Overdose Deaths in Minnesota, Klobuchar Renews Call for Passage of Her Bipartisan Bill to Crack Down on Synthetic Opioids from Overseas
March 30, 2017 Portman, Klobuchar Introduce Legislation to Require Use of Prescription Drug Monitoring Programs Before Prescribing Powerful Painkillers
March 30, 2017 Klobuchar, Portman Introduce Legislation to Require Use of Prescription Drug Monitoring Programs Before Prescribing Powerful Painkillers
March 29, 2017 Pro-Consumer Groups Back Klobuchar's Bipartisan Legislation to Crack Down on Anti-Competitive Pay-for-Delay Pharmaceutical Deals
March 29, 2017 As Health Care Debate Shifts, Senator Franken and Senate Colleagues Lead Milestone Effort to Bring Down Prescription Drug Prices
March 21, 2017 Letter to the Hon. Mitch McConnell - Regarding Opioid Crisis
March 8, 2017 Letter to the Hon. Rex Tillerson, Secretary of State - Work with United Nations to Take Action on Illicit Fentanyl
March 8, 2017 Klobuchar and Bipartisan Group of Senators Introduce Legislation to Save and Protect Recovering Opioid Addicts
March 3, 2017 Senators Re-Introduce LifeBOAT Act
Feb. 21, 2017 CNN - Stop trafficking of synthetic heroin through the mail
Feb. 17, 2017 Letter to the Hon. Jean-Claude Junker, President of the European Commission - European Union Support to Combat the Fentanyl Crisis
Feb. 14, 2017 Letter to the Honorable Tom Price, Secretary of Health and Human Services - Permit Safe Importation of Prescription Drugs from Canada
Feb. 14, 2017 Portman, Klobuchar, Rubio, Hassan Introduce Legislation to Address Overdose Spike From Synthetic Opioids
Feb. 3, 2017 Letter to the Hon. Donald Trump - Regarding Fighting the Opioid Crisis
Feb. 3, 2017 Letter to the Hon. Donald J. Trump - Healthcare Repeal and the Opioid Crisis
Jan. 25, 2017 Grassley on Bipartisan Legislation to Help Fight Dangerous Synthetic Drugs
Jan. 25, 2017 Klobuchar and Bipartisan Group of Senators Introduce Legislation to Help Fight Synthetic Drugs
Jan. 17, 2017 Letter to the Hon. Chuck Rosenberg - Regarding Query on Enforcement Efforts Against Wholesale Opioid Distributors
Jan. 9, 2017 After Klobuchar, Stanek Efforts, Hennepin County Sheriff's Office to Receive Replacement Narcan Applicators
Jan. 5, 2017 Letter to Teleflex CEO, Benson Smith - Take Immediate Action to Ensure Its Equipment Functions Properly
Dec. 6, 2016 Grassley Continues Push to Combat Rising Drug Prices
Oct. 28, 2016 Letter to the Hon. Loretta Lynch, U.S. Attorney General and the Hon. Chuck Rosenberg, Acting Administrator, DEA - Efforts Against Wholesale Opioid Distributors
Oct. 14, 2016 Letter to Mr. Werner Sipp, President, International Narcotics Control Board - Take Action to Regulate Fentanyl
Oct. 13, 2016 Letter to Mr. Werner Sipp, President of the Intl. Narcotics Control Board - Call on UN to Take Action to Regulate Precursor Chemicals of Fentanyl
Oct. 12, 2016 Klobuchar, Franken, Emmer Announce Nearly $650,000 for Drug Court and Veterans Treatment Court in Anoka County
Oct. 5, 2016 King, Colleagues Praise DEA Decision to Lower Opioid Quotas
Sept. 22, 2016 Prescription Opioid and Heroin Epidemic Awareness Week
Sept. 7, 2016 ObamaCare
Aug. 30, 2016 Letter to Ms. Heather Bresch, Chief Executive Officer of Mylan - Concerns About Mylan's EpiPen Price HIke
Aug. 24, 2016 Letter to Dr. Robert M. Califf, Commissioner of the Food and Drug Administration - Account for Any Alternatives to the EpiPen Amid Product Cost Increase
Aug. 4, 2016 Letter to Chuck Rosenberg, Acting Administrator of the Drug Enforcement Administration - Request Update on DEA Efforts to Monitor Controlled Substances Prescribers
Aug. 2, 2016 Letter to The Honorable Andy Slavitt, Acting Administrator, Centers for Medicare & Medicaid Services - Urging CMS to Expand Substance Abuse Treatment Coverage
July 19, 2016 Letter to The Honorable Chuck Rosenberg, Acting Administrator, United States Drug Enforcement Administration - Calling for Stricter Limits on Opioid Pills
July 14, 2016 Letter to Mitch McConnell, Majority Leader of the United States Senate - As Congress Clears Comprehensive Addiction and Recovery Bill, Reed Calls for Emergency Funding for Opioid Epidemic
Skip to top

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.

Back to top